Page History
...
Patients on dialysis are displayed as 'level 5' CKD.
Patients with an eGFR = 0 and no ACR are displayed without action plan level and just with the word 'Stage' to indicate that there is some data in their record that requires review.
Red | Orange | Yellow | No Colour |
For more information refer to Kidney Health Australia web site and the CKD Guideline Booklet available at www.kidney.org.au
Detection of CKD requires follow up testing once an abnormal result is recorded. The outcome of 3 tests over a 3 month period will inform a diagnosis. CAT4 is only using the most recent eGFR and ACR, not the last 3 results. This will
•inform a diagnosis if 3 tests have been done or
•flag that a patient should be recalled for follow up testing if there are not 3 results in the Patient Record.
...
The "Indicated Diabetes with no Diagnosis" Report will display the likelihood of Diabetes based on HbA1c, Anti-diabetic Medication and/or FBG being recorded in the patient record without a diagnosis:
•Red = likely
•Orange = possible
•Yellow = flag for review
Red: ANY of the following | Orange: ANY of the following | Yellow : ANY of the following |
Medications need to be long term to be included.
The report displays
•HbA1c, Anti-diabetic Medication, FBG and the resulting likelihood
•Diabetes Care items that have been recorded
Pen CS wishes to acknowledge the input of Dr Ralph Audehm in the creation of this report.
...
The "Indicated Mental Health with no diagnosis" Report will display the likelihood of a Mental Health condition based on a mental health medication or a mental health care plan being recorded in the patient record without a diagnosis. Any mental health diagnoses included in the existing CAT4 reports/filters is considered regardless if the diagnosis is marked as active or inactive in the patient record.
•Red = likely
•Orange = possible
RED: | ORANGE: |
The report displays
•MH medication, MH MBS item numbers and the resulting likelihood
•Chronic disease co-morbidities
•Other MH risk factors
Pen CS wishes to acknowledge the input of Noel Stewart from NEVDGP and his work in the use of CAT to manage patients with chronic disease and mental health conditions in the creation of this report.
...
Warning |
---|
Please note that currently only POST values for spirometry are taken into consideration in this report! |
RED: | ORANGE: |
The report displays
•COPD medication, spirometry readings and the resulting likelihood
•Chronic disease co-morbidities
•Management items
For more information refer to
- 'The Spirometry Handbook' available from http://www.nationalasthma.org.au
- 'The Pocket Guide to COPD Diagnosis, Management, and Prevention' available from http://www.goldcopd.org
- Respiratory medication filter in CAT4: Respiratory Medications
COPD Management Tiotropium (LAMA) | Generic Name: Tiotropium |
COPD Management - Other (LAMA) | Trade Name: BRETARIS GENUAIR (ACLIDINIUM) SEEBRI BREEZHALER (GLYCOPYRRONIUM) INCRUSE ELLIPTA (UMECLIDINIUM) |
COPD LABA Medications | ONBREZ BREEZHALER (INDACATEROL) |
COPD LAMA/LABA Medications | SPILOTO RESPIMAT (Tiotropium/Olodatererol) BRIMICA GENUAIR (Aclidinium/Formoterol) ULTIBRO BREEZHALER (Indacaterl/glycopyrroium) ANORO ELLIPTA (Umeclinium/vilannterol |
A FEV1/FVC ratio of less than 0.7 indicates airflow limitation.
The predicted normal values are dependent on age, gender and height. The tables are provided in Appendix B of 'The Spirometry Handbook'.
...
The "Indicated Osteoporosis with no diagnosis" prompt will display when a patient meeting the criteria below is opened in the clinical system. The likelihood of the patient having osteoporosis rises from Yellow over Orange to Red as per the table below.
Red - Likely • Aged > 50 with a coded history of a Minimal trauma fracture) • On treatment and without a cancer diagnosis | Orange – Possible • On treatment (Medication) | Yellow – Review • On treatment (Medication) and with a cancer diagnosis |
The report will provide the following fields:
...
The "Medication review > Diabetes with elevated HbA1c" Report will display patients with Type 2 Diabetes whose HbA1c is not being controlled on their current Antidiabetic medications.
Patients will appear on the report where they meet the following criteria:
•Diabetes Type 2
•HbA1c > 8%
The report will display the Antidiabetic medications the patient is currently taking:
Oral Hyperglycaemics | Injectables |
This report provides the opportunity to review and modify the medications being taken to try and bring the HbA1c level into normal range. It also relates to the Diabetes SIP item 'medication review' that should be performed yearly for patients with diabetes.
...